The aminoglycoside group of antibiotics is relatively inactive against enterococci and these compounds are not usually considered for the treatment of enterococcal infections. However, combinations of aminoglycosides with penicillins can be shown to produce bactericidal synergy against many strains of enterococci, and combined penicillin/aminoglycoside therapy is recommended for the treatment of severe infections, notably enterococcal endocarditis (Garrod et al., 1973) . Synergism is not always demonstrated in vitro by combinations of penicillins and aminoglycosides and is dependent upon the level of resistance of the organism to the aminoglycoside. Thus a number of strains of enterococci are highly resistant to streptomycin or kanamycin, and combinations of penicillin and streptomycin or penicillin and kanamycin are not synergistic against these strains (Standiford et al., 1970; Moellering et al., 1971; Russell and Sutherland, 1975) .
The aminoglycoside group of antibiotics is relatively inactive against enterococci and these compounds are not usually considered for the treatment of enterococcal infections. However, combinations of aminoglycosides with penicillins can be shown to produce bactericidal synergy against many strains of enterococci, and combined penicillin/aminoglycoside therapy is recommended for the treatment of severe infections, notably enterococcal endocarditis (Garrod et al., 1973) . Synergism is not always demonstrated in vitro by combinations of penicillins and aminoglycosides and is dependent upon the level of resistance of the organism to the aminoglycoside. Thus a number of strains of enterococci are highly resistant to streptomycin or kanamycin, and combinations of penicillin and streptomycin or penicillin and kanamycin are not synergistic against these strains (Standiford et al., 1970; Moellering et al., 1971 ; Russell and Sutherland, 1975) .
The newer aminoglycosides, gentamicin and tobramycin, are more active in vitro than streptomycin and kanamycin against enterococci (MoellerReceived for publication 20 September 1976 ing Russell and Sutherland, 1975; lannini et al., 1976) , and amikacin, a semisynthetic derivative of kanamycin, is as active as kanamycin against these organisms (lannini et al., 1976) . Enterococci that are resistant to high levels of streptomycin or kanamycin are sensitive to these new aminoglycosides, and combined therapy with the new compounds and penicillins has been proposed for enterococcal infections (Moellering et al., 1971; Moellering et al., 1973; Ruhen and Darrell, 1973; Russell and Sutherland, 1975; lannini et al., 1976) .
There have been no reports in the literature of enterococci resistant to gentamicin, tobramycin or amikacin, but during a study in this laboratory of bacteria isolated from various hospitals during (Jacob and Hobbs, 1974) were unsuccessful, although haemolysin production, which is known to be plasmid-mediated (Jacob et al., 1975) was transferred from Strep. faecalis C134 to the recipient strain in these tests. Also no loss of gentamicin resistance was observed after growth of the cultures in the presence of ethidium bromide, acridine-orange or incubation at 44°C, under which conditions haemolysin production was eliminated from Strep. faecalis C134. In contrast, transfer of streptomycin and kanamycin resistance was demonstrated from strains of Strep. faecalis with high level resistance (MIC > 5000 ,ug/ml) to the recipient strain of Strep. faecalis JH2-2 under the same conditions.
BACTERICIDAL SYNERGISM STUDIES
The results of tests to determine the minimum bactericidal concentrations (MBC) of combinations of amoxycillin and the aminoglycosides against a number of clinical isolates of Strep. faecalis of different aminoglycoside sensitivities are shown in Table 3 . Amoxycillin was ineffective in these tests (MBC > 100 ,pg/ml), but in combination with sublethal concentrations of the aminoglycosides, amoxycillin MBC values (5-0 ,g/ml) against the aminoglycoside sensitive strain of Strep. faecalis (T1089) were not greatly in excess of inhibitory concentrations (ca 1 0 tkg/ml). Against the streptomycinresistant strain Cl 19, the amoxycillin/streptomycin combination was not bactericidal but the other combinations were as effective against this strain as against the sensitive strain, T1089. Similarly, the amoxycillin/streptomycin and amoxycillin/kanamycin combinations failed to demonstrate bactericidal activity against the streptomycin/kanamycin resistant strain of Strep. faecalis C36. Unexpectedly, the MBC of the amoxycillin/amikacin combination was in excess of 100 ,ug amoxycillin/ml + 20 ,ug amikacin/ ml, although the organism showed typical sensitivity to amikacin in the growth inhibition tests (MIC 50 ,g/ml). Similar results were obtained in tests with the other seven kanamycin-resistant strains isolated in this study, and amoxycillin/amikacin and benzyl- (20) 'Strain number. 'Aminoglycoside concentration (u.g/ml); the aminoglycosides were ineffective at these concentrations.
S, streptomycin; K, kanamycin; G, gentamicin.
'Growth often occurred on subculture from tubes containing higher concentrations. penicillin/amikacin combinations failed to produce synergistic bactericidal effects against any of the kanamycin-resistant (amikacin-sensitive) strains of Strep. faecalis. There was no evidence of crossresistance with the amoxycillin/gentamicin and amoxycillin/tobramycin combinations against the kanamycin-resistant strain Strep. faecalis C36, and both combinations produced marked bactericidal activity against this strain and other kanamycinresistant enterococci.
The gentamicin-resistant isolates responded in a more variable fashion to amoxycillin/aminoglycoside combinations in the bactericidal tests compared with gentamicin-sensitive strains. In the MBC tests, sensitive strains gave a sharp end-point so that no growth was observed on subculture from combinations containing amoxycillin at concentrations of 5 0 ,ug/ml or more. With the gentamicin-resistant strains there was no growth from cultures containing 5 0 ug amoxycillin/ml or 10 ,ug amoxycillin/ml in combination with the aminoglycosides but growth sometimes occurred in subcultures from tubes containing higher concentrations-of amoxycillin. In the viable count tests, gentamicin-sensitive strains of Strep. faecalis were always sterilised by combinations of 2 5 ,ug amoxycillin plus 50 ,ug gentamicin/ml whereas, with the gentamicin-resistant strains, on some occasions the cultures were made sterile, but on repeat tests viable bacteria were often recovered (Table 4) . Similar variable responses were observed with combinations containing other aminoglycosides.
Discussion
The results reported here for a limited number of recent clinical isolates of Strep. faecalis show the prevalence of a relatively high proportion of strains with reduced sensitivity to aminoglycoside antibiotics. Strains resistant to streptomycin or kanamycin demonstrated a high level of resistance to the compounds but were sensitive to gentamicin, tobramycin or amikacin. In contrast, the strains with reduced sensitivity to gentamicin showed a moderate level of resistance to gentamicin and to the other aminoglycosides.
Enterococci with a high level of resistance to streptomycin have been known for some time (Havard et al., 1959) , and more recent reports have described a relatively high incidence of resistance to streptomycin and kanamycin (Standiford et al., Aminoglycoside-resistant enterococci 1970; Moellering et al., 1971; Ruhen and Darrell, 1973; lannini et al., 1976) . In this study, the streptomycin-resistant strains of Strep. faecalis isolated in 1975 were almost always resistant to kanamycin which contrasts with the results of earlier studies reported from this laboratory. For example, none of 10 streptomycin-resistant strains of Strep. faecalis isolated in 1961 and only two of 15 streptomycinresistant strains isolated in 1967 were resistant also to kanamycin (Sutherland and Rolinson, 1964; Russell and Sutherland, 1975) . The apparent increase in the proportion of kanamycin-resistant strains relative to streptomycin-resistant strains observed here may be a reflection of increased usage of kanamycin, but the number of strains tested was very small.
Enterococci with a high level of resistance to streptomycin or kanamycin have been shown to be sensitive to gentamicin, tobramycin, and amikacin (lannini et al., 1976) , and bactericidal synergy has been demonstrated by a combination of penicillins and gentamicin or tobramycin against these resistant strains (Moellering et al., 1971; Moellering et al., 1973; Ruhen and Darrell, 1973; Russell and Sutherland, 1975) . The results of this study are in agreement with these reports but the failure to demonstrate synergism with penicillin/amikacin combinations against kanamycin-resistant strains of Strep. faecalis was unexpected in view of the apparent sensitivity of these organisms to amikacin. Amikacin/ penicillin combinations produce synergistic effects against kanamycin-sensitive strains, and the lack of synergy against kanamycin-resistant strains is evidence of cross-resistance between kanamycin and amikacin which is not observed in growth-inhibition tests.
Gentamicin-resistant enterococci have not been reported previously in the literature, and the strains described here do not show the high level of resistance which is characteristic of streptomycin and kanamycin-resistant enterococci. Nevertheless the concentrations of gentamicin required to inhibit growth of the two cultures of Strep. faecalis (250 to 500 ,ug/ml) were notably higher than the levels required to inhibit the majority of strains (5-0-12-5 ,ug/ml). Moreover, the variable results obtained in the bactericidal tests with these two strains contrasted with the uniform bactericidal synergy observed with combinations of amoxycillin and gentamicin against sensitive strains of Strep. faecalis. The rationale for the use of penicillin/ aminoglycoside combinations in the treatment of enterococcal infections has been largely based upon the fact that such combinations can sterilise cultures of enterococci in vitro (Garrod et al., 1973) , but with these gentamicin-resistant strains this effect was not always observed.
The characteristics of the gentamicin-resistant clinical isolates, namely, the moderate level of resistance and degree of cross-resistance with other aminoglycosides, were markedly similar to those of the resistant strains selected in vitro after subculture in the presence of gentamicin. These findings, coupled with the failure to demonstrate conjugal transfer of resistance or to eliminate resistance with curing agents, suggest that the strains might have arisen in vivo by selection as a result of therapy with topical gentamicin, as has been reported for Pseudomonas aeruginosa (Snelling et al., 1971; Holmes et al., 1974) and, more recently, for Staphylococcus aureus (Porthouse et al., 1976; Warren and Roberts,1976) .
Therapy with benzylpenicillin and streptomycin has often been recommended as the treatment of choice for severe enterococcal infections but awareness of the increasing incidence of streptomycin and kanamycin-resistant strains has led to an increased interest in the activity of combinations of penicillins with newer aminoglycosides, namely, gentamicin, tobramycin, and amikacin. The finding of strains that are apparently less sensitive to these compounds emphasises the need for appropriate laboratory tests for the selection of the most suitable penicillin/ aminoglycoside combination for therapy of enterococcal infections.
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